3rd International Conference on Rare Diseases and Orphan Drugs

Coalesce Research Group is pleased to announce the 3rd International Conference on Rare Diseases and Orphan Drugs, set to take place on October 27–28, 2025, in Singapore City, Singapore. This two-day conference is designed to serve as a global platform for experts, stakeholders, and advocates to discuss advancements, challenges, and opportunities in the rare diseases and orphan drugs sector.

The primary objective of Rare Diseases 2025 is to raise awareness, foster collaboration, and accelerate progress in addressing the complex needs of individuals affected by rare diseases. The conference will facilitate dialogue and knowledge exchange among diverse stakeholders involved in rare disease research, drug development, patient care, advocacy, and policy-making.

The conference may cover a wide range of topics related to rare diseases and orphan drugs, including but not limited to:

Disease epidemiology and genetics
Advances in diagnosis and screening
Therapeutic interventions and treatment approaches
Drug discovery and development strategies
Regulatory pathways and orphan drug designation
Patient-centered care and access to treatments
Health economics and reimbursement issues
Patient advocacy, support, and empowerment
Rare Diseases 2025 features keynote presentations, plenary sessions, panel discussions, poster presentations, workshops and networking opportunities. It may also include exhibits showcasing the latest advancements in rare disease research, diagnostics, and therapeutics.

Overall, Rare Diseases 2025 plays a crucial role in advancing research, innovation, and collaboration to improve outcomes and quality of life for individuals living with rare diseases

Who Can Attend?

Medical Professionals: Doctors, Specialists, Nurses and Pharmacists
Researchers and Scientists
Pharmaceutical Industry Representatives
Patient Advocates and Organizations
Regulatory Authorities
Healthcare Administrators
Academics and Educators
Investors and Venture Capitalists
Government Representatives: Policymakers, Lawmakers and Government Officials
Industry Stakeholders

Conference Scientific Sessions

Rare Diseases and Orphan Drugs
Introduction and Causes of New Rare Diseases
Clinical Case Reports and Case Studies
Different types of rare diseases
Challenges of living with a rare disease
Rare Diseases Vs Common Diseases
Rare Autoimmune Disorders
Rare Bone Diseases
Rare Cancer
Rare skin diseases
Rare nutritional and metabolic diseases
Rare pediatric diseases
Mystery Diagnosis of Rare Diseases
Rare Syndrome in Covid-19
Rare Neurological Disorders
Rare Diseases of the Heart and Vessels
Patient Advocacy Group
Clinical Research on Orphan Drugs
Orphan drugs potentiality
Aging Rare Diseases
Mosaicism in rare disease
Drug discovery for rare diseases
Sickle Cell Anaemia
Bio medical research
Chromosomal Abnormalities
X-linked and mitochondrial disorders
Advancement in the diagnosis of rare diseases
Emerging in technologies in rare diseases research
Regulatory considerations for developing orphan drugs
Treatment and advanced therapies for rare diseases
Infectious Diseases and Immune Deficiencies
Genetic Testing and counselling of Rare Diseases
Biomarkers for rare disease diagnosis and treatment
Functional Genomics and Gene Therapy for Rare Diseases
Vaccines and vaccination for rare diseases
Health Economics and Market Access for Orphan Drugs